查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614234

依普拉嗪市场：按适应症、按产品、按分销管道、按管理方法分类 - 全球预测 2025-2030

Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年依拉嗪酮市场估值为172.3亿美元，预计2024年将达到186亿美元，复合年增长率为8.11%，预计2030年将达到297.5亿美元。

依普拉嗪酮是一种用于治疗呼吸系统疾病的支气管扩张剂，并以其治疗用途为中心拥有特定的市场利基。对依拉嗪的需求主要源自于其在治疗支气管炎和气喘等慢性呼吸道疾病的功效，透过放鬆支气管肌肉来缓解症状。这种药物针对的是不断增长的人口，因为呼吸系统疾病的盛行率正在上升，部分原因是污染增加和生活方式的改变。最终用途范围主要是医疗保健设施，包括医院、诊所和一些门诊居家照护。市场成长要素包括对有效呼吸治疗的需求不断增加以及可提高临床效果的药物输送系统的进步。然而，透过策略伙伴关係关係扩大依拉嗪酮市场以及进入呼吸系统疾病流行且药品获取情况正在改善的新兴国家，存在潜在的商机。公司应专注于研发投资，以使其产品阵容多样化并改进配方，以提高功效并减少副作用。另一方面，严格的法规环境、与使用依拉嗪酮相关的潜在副作用以及竞争性替代疗法的存在对市场成长构成了挑战。其他主要限制因素包括医疗保健预算的波动和保险范围不匹配，这可能会阻碍市场渗透。创新领域包括探索与其他呼吸系统药物的协同效应组合，以及利用吸入器和雾化器等新颖的给药技术来提高患者的用药依从性。市场竞争温和，大大小小的製药公司相互竞争，差异化需要战略倡议，例如联盟和以患者为中心的方法。强大的药品研发流程和监管合规性会对市场动态产生重大影响，公司需要优先考虑全面的安全标准和全球市场扩大策略以实现永续成长。

主要市场统计
基准年[2023] 172.3亿美元
预测年份 [2024] 186亿美元
预测年份 [2030] 297.5亿美元
复合年增长率（%） 8.11%

市场动态：揭示快速发展的依拉嗪酮市场的关键市场洞察

供需的动态交互作用正在改变依拉嗪酮市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球呼吸系统疾病盛行率上升
    • 由于投资增加而扩大製药业
  • 市场限制因素
    • 与依拉嗪酮相关的高药物配方成本
  • 市场机会
    • 加大依拉嗪酮新剂型的开发
    • 增加依拉嗪酮的监管核准
  • 市场挑战
    • 对依拉嗪酮的益处认识不足

波特的五力：驾驭依普拉吉农市场的策略工具

波特的五力框架是了解 Epraginone 市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对依拉嗪酮市场的外部影响

外部宏观环境因素在塑造依拉嗪酮市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解依普拉吉农市场的竞争状况

对依拉嗪酮市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵 Epraginone 市场供应商的绩效评估

FPNV定位矩阵是评估Eprrazinone市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了依普拉嗪酮市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对依普拉嗪市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地呼吸系统疾病的发生率正在上升
      • 加大投资扩大医药领域
    • 抑制因素
      • 与依拉嗪酮相关的处方药物高成本
    • 机会
      • 依拉嗪酮新剂型开发取得进展
      • 增加依拉嗪酮的监管核准
    • 任务
      • 对依拉嗪酮益处的认识有限
  • 市场区隔分析
    • 适应症：透过减少发炎和放鬆气道来治疗支气管气喘，对依拉嗪酮的需求增加
    • 产品：优选依拉嗪片，因为它们可以精确调整药物剂量。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 依拉嗪市场适应症

  • 支气管气喘
  • 慢性/急性咳嗽
  • 慢性呼吸衰竭
  • 咳嗽
  • 慢性/急性支气管炎的祛痰药
  • 流感
  • 鼻炎

第七章 依拉嗪市场：副产品

  • 液体
  • 锭剂

第八章依拉嗪市场：按分销管道

  • 电子商务平台
  • 医院药房
  • 网路药房

第九章 依拉嗪酮市场管理方法

  • 静脉
  • 口服

第10章 美洲依拉嗪酮市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区依拉嗪酮市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲依拉嗪酮市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Biosynth 收购 Biochemicals 加强供应链服务
    • Accelerated Access Collaborative 宣布投资 1,100 万欧元用于中风、心血管和呼吸系统疾病创新
  • 战略分析和建议

公司名单

  • BenchChem
  • Biosynth Ltd
  • BOC Sciences
  • Clearsynth
  • HK Starshine Printing Design Co., Ltd.
  • J&H CHEM Co., Ltd.
  • MedicaPharma BV
  • MuseChem Chemicals
  • Nordic Biosite
  • Procurenet Limited
  • RR Scientific, LLC
  • RayBiotech, Inc.
  • VIVAN Life Sciences
Product Code: MRR-F97DD5A7D578

The Eprazinone Market was valued at USD 17.23 billion in 2023, expected to reach USD 18.60 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 29.75 billion by 2030.

Eprazinone, a bronchodilator utilized for respiratory disorders, has a specified market niche centered around its therapeutic application. Primarily, the need for eprazinone arises from its efficacy in treating chronic respiratory diseases such as bronchitis and asthma, offering symptomatic relief by relaxing bronchial muscles. This drug caters to a growing demographic due to the rising prevalence of respiratory diseases, partly driven by increasing pollution and lifestyle changes. The end-use scope primarily encompasses healthcare facilities, including hospitals, clinics, and some outpatient home-care settings. Market growth factors include the increasing demand for effective respiratory treatments and advancements in drug delivery systems that enhance clinical outcomes. However, potential opportunities lie in expanding eprazinone's market through strategic partnerships and tapping into emerging economies where respiratory issues are prevalent and access to medication is improving. Companies should focus on diversifying product offerings and investing in R&D for improved formulations to enhance drug efficacy and reduce side effects. On the flip side, market growth is challenged by stringent regulatory environments, potential adverse reactions associated with eprazinone usage, and the competitive presence of alternative treatments. Key limitations also include fluctuating health care budgets and insurance coverage discrepancies that may hinder market penetration. Innovation areas involve exploring synergistic combinations with other respiratory drugs and leveraging novel delivery technologies like inhalers and nebulizers for better patient adherence. The market is moderately competitive, with several small and large pharmaceutical players competing, necessitating strategic initiatives such as collaboration and patient-centric approaches for differentiation. Robust pharmaceutical R&D processes aligned with regulatory compliance can significantly influence market dynamics, encouraging businesses to prioritize comprehensive safety standards and global market expansion strategies for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.23 billion
Estimated Year [2024] USD 18.60 billion
Forecast Year [2030] USD 29.75 billion
CAGR (%) 8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Eprazinone Market

The Eprazinone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of respiratory diseases worldwide
    • Expanding the pharmaceutical sector with increasing investments
  • Market Restraints
    • High cost of formulations of medications associated with eprazinone
  • Market Opportunities
    • Growing development of new formulations of eprazinone
    • Rising approvals for eprazinone by regulatory authorities
  • Market Challenges
    • Limited awareness associated with the benefits of eprazinone

Porter's Five Forces: A Strategic Tool for Navigating the Eprazinone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Eprazinone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Eprazinone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Eprazinone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Eprazinone Market

A detailed market share analysis in the Eprazinone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Eprazinone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Eprazinone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Eprazinone Market

A strategic analysis of the Eprazinone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Eprazinone Market, highlighting leading vendors and their innovative profiles. These include BenchChem, Biosynth Ltd, BOC Sciences, Clearsynth, HK Starshine Printing Design Co., Ltd., J&H CHEM Co., Ltd., MedicaPharma BV, MuseChem Chemicals, Nordic Biosite, Procurenet Limited, R.R Scientific, LLC, RayBiotech, Inc., and VIVAN Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Eprazinone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Bronchial asthma, Chronic / acute cough, Chronic respiratory failure, Cough, Expectorant in chronic/acute bronchitis, Flu, and Rhinitis.
  • Based on Product, market is studied across Liquid and Tablet.
  • Based on Distribution Channel, market is studied across eCommerce Platforms, Hospital Pharmacies, and Online Pharmacies.
  • Based on Mode of Administation, market is studied across Intravenous and Oral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases worldwide
      • 5.1.1.2. Expanding the pharmaceutical sector with increasing investments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulations of medications associated with eprazinone
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of new formulations of eprazinone
      • 5.1.3.2. Rising approvals for eprazinone by regulatory authorities
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness associated with the benefits of eprazinone
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways
    • 5.2.2. Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Eprazinone Market, by Indication

  • 6.1. Introduction
  • 6.2. Bronchial asthma
  • 6.3. Chronic / acute cough
  • 6.4. Chronic respiratory failure
  • 6.5. Cough
  • 6.6. Expectorant in chronic/acute bronchitis
  • 6.7. Flu
  • 6.8. Rhinitis

7. Eprazinone Market, by Product

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Tablet

8. Eprazinone Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. eCommerce Platforms
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies

9. Eprazinone Market, by Mode of Administation

  • 9.1. Introduction
  • 9.2. Intravenous
  • 9.3. Oral

10. Americas Eprazinone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Eprazinone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Eprazinone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Biosynth acquires Vio Chemicals to Fortify its Supply Chain Services
    • 13.3.2. Accelerated Access Collaborative announces Euro 11 million investment in stroke, cardiovascular disease and respiratory innovations
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BenchChem
  • 2. Biosynth Ltd
  • 3. BOC Sciences
  • 4. Clearsynth
  • 5. HK Starshine Printing Design Co., Ltd.
  • 6. J&H CHEM Co., Ltd.
  • 7. MedicaPharma BV
  • 8. MuseChem Chemicals
  • 9. Nordic Biosite
  • 10. Procurenet Limited
  • 11. R.R Scientific, LLC
  • 12. RayBiotech, Inc.
  • 13. VIVAN Life Sciences

LIST OF FIGURES

  • FIGURE 1. EPRAZINONE MARKET RESEARCH PROCESS
  • FIGURE 2. EPRAZINONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRAZINONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPRAZINONE MARKET DYNAMICS
  • TABLE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 193. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023